Viewing Study NCT00170820


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-04-10 @ 5:26 AM
Study NCT ID: NCT00170820
Status: COMPLETED
Last Update Posted: 2017-02-27
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module